8-K: NeueHealth Goes Private in $1.5B NEA Acquisition

NeueHealth, Inc. has completed its take-private merger with an affiliate of New Enterprise Associates, with common stockholders receiving $7.33 per share in cash.

Summary

• NeueHealth, Inc. completed its merger with an affiliate of New Enterprise Associates (NEA) on October 2, 2025, becoming a privately held company.
• Common stockholders received $7.33 per share in cash, totaling approximately $22.3 million in aggregate merger consideration.
• The transaction valued the company at an enterprise value of approximately $1.496 billion.
• Certain stockholders, including NEA, 12 existing investors, and the executive leadership team, rolled over their equity interests into the new private entity.
• The company's common stock ceased trading on the New York Stock Exchange on October 2, 2025, and the company intends to delist and deregister its securities.
• A Second Amendment to the Loan and Security Agreement was executed on September 26, 2025, modifying loan terms with Hercules Capital, Inc.
• This amendment included the funding of a $25.0 million Tranche 2A term loan and maintained up to $95.0 million in remaining loan commitments.
• The minimum cash covenant was increased from $15.0 million to $25.0 million, with step-downs to $20.0 million and $15.0 million based on specific milestones.
• NeueHealth issued warrants to NEA affiliates for 1,116,765 shares of common stock at an exercise price of $0.01 per share in a private placement.

Sentiment

Score: 7

Explanation: The filing details the successful completion of a previously announced take-private merger, providing certainty to shareholders (who received cash) and the company's future as a private entity with continued leadership and significant financial backing from NEA. The loan amendment secures additional funding and extends availability, which is positive for liquidity and operational flexibility. While public shareholders lose direct market access, the transaction itself is a planned and executed strategic move.

Positives

• The successful completion of the merger provides the company with increased flexibility and resources as a private entity.
• The company secured an additional $25.0 million in Tranche 2A term loans, enhancing liquidity.
• Remaining loan commitments of up to $95.0 million provide further potential funding.
• Loan funding milestones and availability periods were modified and extended, offering more operational flexibility.
• The executive leadership team will continue in their roles, ensuring continuity.

Negatives

• Public shareholders (excluding rollover holders) received $7.33 per share, which may not reflect optimal value for all.
• The company's common stock was delisted from the NYSE, removing public trading access.
• Options to purchase common stock with an exercise price equal to or greater than the $7.33 per share merger consideration were canceled for no consideration.
• Performance-based restricted stock units were canceled for no consideration.

Risks

• Failure to complete the transaction on anticipated terms and timeframe, including due to failure to obtain required stockholder or regulatory approvals or satisfy other closing conditions.
• Potential litigation relating to the transaction against NEA, the Company, or their affiliates, directors, managers, officers, or employees.
• Potential adverse reactions or changes to business relationships or operating results resulting from the announcement, pendency, or completion of the transaction.
• Risk that the stock price may decline significantly if the transaction is not consummated.
• Certain restrictions during the pendency of the transaction that may impact the ability to pursue certain business opportunities or strategic transactions.
• Costs associated with the transaction, which may be significant.
• Occurrence of events, changes, or other circumstances that could give rise to the termination of the merger agreement, including circumstances requiring a termination fee.
• Ability to continue as a going concern.
• Ability to comply with the terms of credit facilities or any future credit facility.
• Ability to receive remaining proceeds from the sale of the Medicare Advantage business in California in a timely manner.
• Ability to obtain any short or long-term debt or equity financing needed to operate the business.
• Ability to quickly and efficiently complete the wind down of remaining Individual and Family Plan (IFP) and MA businesses, including satisfying liabilities.
• Potential disruptions to the business due to the transaction or corporate restructuring and any resulting headcount reduction.
• Ability to accurately estimate and effectively manage costs relating to changes in business offerings and models.
• Delay or inability to withdraw regulated capital from subsidiaries.
• Lack of acceptance or slow adoption of the business model.
• Ability to retain existing consumers and expand consumer enrollment.
• Ability to obtain and accurately assess, code, and report risk adjustment factor scores.
• Ability to contract with care providers and arrange for the provision of quality care.
• Ability to obtain claims information timely and accurately.
• Impact of any pandemic or epidemic on business and results of operations.
• Risks associated with reliance on third-party providers to operate the business.
• Impact of modifications or changes to the U.S. health insurance markets.
• Ability to manage any growth of the business.
• Ability to operate, update, or implement the technology platform and other information technology systems.
• Ability to retain key executives.
• Ability to successfully pursue acquisitions, integrate acquired businesses, and quickly and efficiently divest businesses as needed.
• Occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest.
• Ability to prevent and contain data security incidents and the impact of data security incidents on members, patients, employees, and financial results.
• Ability to comply with requirements to maintain effective internal controls.
• Ability to adapt to mitigate risks associated with ACO businesses, including unanticipated market or regulatory developments.

Future Outlook

The company, now privately held, anticipates increased flexibility and resources to advance its value-driven, consumer-centric care model and drive long-term, sustainable growth. It will continue its mission of aligning interests of consumers, payors, and providers to create a seamless, coordinated care experience.

Management Comments

• "This transaction marks a significant milestone for our Company as it allows us the flexibility and resources to continue to fulfill this mission as we advance our value-driven, consumer-centric care model and drive long-term, sustainable growth into the future." Mike Mikan, President and CEO of NeueHealth.

Industry Context

NeueHealth operates in the value-driven healthcare sector, focusing on the ACA Marketplace, Medicare, and Medicaid. Its business model emphasizes aligning interests of consumers, providers, and payors to deliver high-quality, coordinated care. The take-private transaction by a major venture capital firm like NEA suggests a belief in the long-term potential of this model, potentially allowing for strategic investments and operational changes away from public market pressures, which is a common trend for companies seeking to innovate or restructure in complex industries like healthcare.

Management Changes

Corporate Governance

Related Party Transactions

• The merger involved NH Holdings 2025, Inc. and Merger Sub, which are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. (NEA).
• Certain stockholders, including NEA and 12 existing NeueHealth investors, entered into rollover agreements to exchange their equity for interests in the privately held company.
• The funds used by Parent to consummate the Merger came from an increase in the Company's existing subordinated credit facility with NEA and other lenders.
• Warrants representing the right to purchase 1,116,765 shares of Company Common Stock at $0.01 per share were issued to NEA affiliates (NEA 18 Venture Growth Equity, L.P., New Enterprise Associates 15, L.P., New Enterprise Associates 16, L.P., and New Enterprise Associates 17, L.P.).

Stakeholder Impact

• Shareholders (Common Stock): Received $7.33 per share in cash, losing their equity stake and public market access.
• Shareholders (Preferred Stock & Rollover Holders): Exchanged their equity for interests in the privately held company, maintaining an investment in the new structure.
• Employees (Executive Leadership): Continue in their roles and rolled over their equity interests, indicating stability at the top.
• Lenders (Hercules Capital, Inc.): Loan terms were amended, and additional funds were disbursed, indicating continued financial relationship and support.
• Customers/Providers: The company's mission to deliver value-driven, consumer-centric care is expected to continue, potentially benefiting from increased flexibility and resources as a private entity.
• Regulatory Bodies (SEC, NYSE): The company will cease public reporting and delist, reducing regulatory oversight requirements.

Next Steps

• The company intends to file a Notification of Removal from Listing and/or Registration on Form 25 with the SEC to delist its common stock from NYSE and deregister it under Section 12(b) of the Exchange Act.
• Upon effectiveness of Form 25, the company intends to file a Form 15 with the SEC to deregister its securities under Section 12(g) and suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act.
• The company will continue to advance its value-driven, consumer-centric care model and drive long-term, sustainable growth as a private entity.

Key Dates

Recommendation

For public shareholders, the recommendation is 'sell' because the company has completed its take-private transaction, and common stock has been converted to cash at $7.33 per share. The stock has ceased trading on the NYSE, and the company will be delisted, meaning there is no longer a public market for the shares. Shareholders who have not yet received their cash consideration should ensure they do so.

Keywords

Healthcare, Merger, Acquisition, Take-private, NEA, NeueHealth, NYSE Delisting, Loan Amendment, Private Equity, Healthcare Technology, Value-based Care, Medicare, Medicaid, ACA Marketplace